<DOC>
	<DOCNO>NCT03078881</DOCNO>
	<brief_summary>This Pre-Phase 1 prospective , non-interventional clinical assessment study evaluate Crigler-Najjar syndrome subject require daily phototherapy , age 1 year older .</brief_summary>
	<brief_title>Clinical Assessment Study Crigler-Najjar Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Crigler-Najjar Syndrome</mesh_term>
	<criteria>Key Subject diagnosis CriglerNajjar syndrome result confirm mutation UGT1A1 gene Subject age equal great 1 year age Subject receive daily phototherapy minimum 6 hour within 24hour period ( daily illumination time ) Subject currently participate interventional study receive gene cell therapy Subject receive whole liver , partial liver , hepatocyte transplant ; subject liver transplant schedule within planned participation period study Subject significant cholestatic disease , opinion investigator Subject receive phenobarbital know inducer UGT1A1 within 30 day screen Subject clinically significant underlying liver disease ( CriglerNajjar syndrome ) , opinion investigator Subject history , currently , clinically important condition CriglerNajjar syndrome , opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>